Previous 10 | Next 10 |
MELBOURNE, Australia, May 23, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce that the Company’s geneType Brea...
2023-05-03 23:45:09 ET Genetic Technologies Limited (GENE) Q3 2023 Earnings Conference Call May 03, 2023 05:00 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - Chief Executive Officer Tony Di Pietro - Chief Financial Officer Co...
MELBOURNE, Australia, April 28, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce the publication of a research paper i...
MELBOURNE, Australia, April 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, releases its Appendix 4C and Quarterly b...
MELBOURNE, Australia, April 19, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce the publication of a research paper i...
MELBOURNE, Australia, March 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and serious disease – is pleased to announce the US launch of th...
2023-03-13 09:46:33 ET Genetic Technologies ( NASDAQ: GENE ) said a research paper published in the journal Cancer Prevention Research supports the use of geneType Breast Cancer risk assessment test. The paper titled, Validation of an abridged breast cancer ris...
MELBOURNE, Australia, March 13, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the publication of another research...
Genetic Technologies Limited (GENE) Q2 2023 Earnings Conference Call Feb 27, 2023, 05:00 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - CEO Tony Di Pietro – CFO Carl Stubbings - Chief Commercial Officer Conference Call P...
Genetic Technologies ( NASDAQ: GENE ) stock rose ~20% on Thursday after the company announce the publication of a research paper in a journal suggesting geneType's ability to detect breast cancer earlier and provide data for risk stratification. The paper — which was p...
News, Short Squeeze, Breakout and More Instantly...
Genetic Technologies Ltd Company Name:
GENE Stock Symbol:
NASDAQ Market:
Genetic Technologies Ltd Website:
CHARLOTTE, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to share the power of the geneType test in identifyin...
CHARLOTTE, N.C. and MELBOURNE, Australia, June 21, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, ASX:GTG, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and ...
CHARLOTTE, N.C., June 18, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, today announces the start of testing operations in the United St...